Investment Summary

Frazier Healthcare Partners Invests In Passage Bio

On January 1, 2018, growth capital firm Frazier Healthcare Partners invested in life science company Passage Bio

Investment Highlights
  • This is Frazier Healthcare Partners’ 13th transaction in the Life Science sector.
  • This is Frazier Healthcare Partners’ 31st transaction in the United States.
  • This is Frazier Healthcare Partners’ 4th transaction in Pennsylvania.
Investment Fate
  • Passage Bio went public in 2020.

Investment Summary

Date 2018-01-01
Target Passage Bio
Sector Life Science
Investor(s) Frazier Healthcare Partners
Deal Type Venture

Target

Passage Bio

Philadelphia, Pennsylvania, United States
Passage Bio is a fully-integrated genetic medicines company developing life-transforming AAV-delivered in vivo therapeutics for the treatment of rare CNS diseases. Passage Bio was founded in 2018 and is based in Philadelphia, Pennsylvania.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor
DESCRIPTION

Frazier Healthcare Partners is a private equity and venture capital firm specializing in Growth buyout investment specifically targets businesses that deal Healthcare, Life Sciences, Pharmaceutical services, medical products, and related sectors. Frazier Healthcare Partners was formed in 1991 and is based in Seattle, Washington with an additional office in Palo Alto, California; Boston, Massachusetts; and Menlo Park, California.


DEAL STATS #
Overall 32 of 48
Sector: Life Science M&A 13 of 17
Type: Venture M&A Deals 12 of 12
State: Pennsylvania M&A 4 of 5
Country: United States M&A 31 of 47
Year: 2018 M&A 3 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-01-01 Amunix

South San Francisco, California, United States

Amunix is an immuno-oncology company focused on designing and developing masked T cell engagers and cytokines to bring the promise of these potent immune-activating biotherapeutics to patients with cancers. Amunix is headquartered in South San Francisco, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-05-01 Abode Healthcare

Durango, Colorado, United States

Abode Healthcare provides a full spectrum of home health and hospice services in attractive, growing markets across the United States. Abode’s service offerings are thoughtfully tailored to patients and families, with focused attention given to individual needs and preferences. Abode Healthcare was formed in 2012 and is based in Durango, Colorado.

Sell -